Business of Cannabis Leadership Summit: April 24 in Toronto

Business of Cannabis: Toronto will bring together influential Canadian business leaders spearheading the industry, key investors and on the ground policy makers to discuss the next 5-years of business in the country and how imminent reform might affect the shape of the market there.

In this leadership summits, Business of Cannabis brings together global players, alongside financial and political figures for half-day laser focused program and high-level networking — to utilise data, insights and knowledge in order to arm businesses to best navigate the next phase of Canadian cannabis.

For more information visit: https://www.cannabistoronto.live/


ISO, SCC and the Canadian Cannabis Industry

ISO, the International Organization for Standardization, is an independent, non-governmental international organization with a membership of 170 national standards bodies.

Through its members, ISO brings together experts to share knowledge and develop voluntary, consensus-based, market relevant International Standards that support innovation and provide solutions to global challenges.

In Canada, the ISO is represented by the Standards Council of Canada (SCC). A Crown corporation, SCC was established by an Act of Parliament in 1970 to foster and promote voluntary standardization in Canada. SCC is independent of government in its policies and operations, although it is financed partially by Parliamentary appropriation.

When Canada legalized cannabis in 2018, SCC set about creating standards for the new industry believing that standards are essential for an effectively regulated marijuana market. These standards were considered groundbreaking when published in October of 2022.
ISO IWA-37, “Safety, security and sustainability of cannabis facilities and operations” is available for purchase through ISO in three parts.

Part 1 (ISO IWA 37-1:2022) covers requirements for the safety of cannabis buildings, equipment and oil extraction operations. https://www.iso.org/standard/84023.html

Part 2 (ISO IWA 37-2:2022) covers requirements for the secure handling of cannabis and cannabis products. https://www.iso.org/standard/84024.html

Part 3 (ISO IWA 37-3:2022) covers good production practices (GPP). https://www.iso.org/standard/84025.html

Taken as a whole, these documents provide invaluable direction to legislative bodies and emerging companies and help to create a safe, legal market for adults who use cannabis.

For more information from SCC visit: https://www.scc.ca/en/news-events/news/2022/new-guidance-from-iso-international-workshop-safe-cannabis-production

For more information from ISO visit: https://www.iso.org/en/contents/news/2022/10/standards_safe_legal_cannabis.html

To learn more about how AirMed helps you meet these standards, visit our Compliance page.

If you’d like to learn about our quality management and GPP offerings or discuss your specific needs, please give us a call at 1-877-313-2442 or use one of the contact forms.


Happy New Year!

Can you believe that 2024 is the 10th year AirMed has been in business? It’s true. We started in 2014!

A lot has happened in our industry during those 10 years, some good and some not-so-good. But we want you to know that we pledge our commitment to continued hard work and innovation, and we see great things on the horizon.

As we look ahead to the coming year, we send best wishes for a future filled with success and abundance to all our industry. Expect 2024 to be a year of new vistas and exciting possibilities for cannabis in Canada. Here’s to moving forward with positivity and purpose.

From everyone at AirMed, Happy New Year!


Season's Greetings

The staff at AirMed would like to wish all our industry the best this holiday season.

And we’d like to take this opportunity to thank all those who supported us this past year. We value the connections we’ve made with clients, future clients and partners as well as with other industry members.

Looking forward to working with you in the future, may this season bring you peace and joy.


MJBizDaily Publishes Series on Government Funding for Canadian Producers

In the first article of a series, MJBiz Daily reported “More Canadian cannabis companies are tapping government funding sources to finance research and other projects as private-sector capital has become harder to come by.”

That article, written by MJBiz Daily International Editor Matt Lamers, was published September 28, 2023 with the title “Canadian cannabis companies tap government funding programs.”

Lamers wrote, “MJBizDaily found that more than 3 million Canadian dollars ($2.2 million) worth of federal funding was provided to almost two dozen companies over the past year, according to the government’s Grants and Contributions portal.”

The second article, published October 3, 2023, reported that “Cannabis-related agricultural businesses based in Alberta are eligible for provincial funding under two programs if they meet certain requirements, the Ministry of Agriculture and Irrigation told MJBizDaily.”

The latest installment, published November 16, 2023, reported that the BC Ministry of Agriculture and Food explained via email that “federally licensed and commercial cannabis production is eligible for many of its programs and services.”

The author wrote, “Federally licensed cannabis producers in British Columbia are eligible to apply for a host of government programs, some of which provide funding, including the provincial portion of the Sustainable Canadian Agricultural Partnership.”


In the News Five Years After Cannabis Legalization in Canada

This month marked the fifth anniversary of the legalization of cannabis in Canada, and news outlets offered various views on the results so far. While some of the articles discussed the challenges and struggles facing the industry, others looked at different aspects.

CTV News reports that “Five years after cannabis legalization, 64 per cent of Canadians are in support of the move.” The article published on the CTV News website was about the results of an online survey conducted by Research Co. “Support for the legalization of marijuana is highest among Canadians aged 55 and over (66 per cent),” Mario Canseco, President of Research Co. said in a press release. “The proportions are lower among those aged 35-to-54 (56 per cent) and those aged 18-to-34 (48 per cent).”

https://www.ctvnews.ca/canada/five-years-after-cannabis-legalization-64-per-cent-of-canadians-are-in-support-of-the-move-survey-1.6621182

The Canadian Medical Association Journal published “Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark.” This scholarly article reported, “Cannabis legalization in Canada appears not to have been the public health disaster anticipated by some of its opponents, but it cannot be described as a comprehensive or unequivocal success for public health either.”

https://www.cmaj.ca/content/195/39/E1351#ref-11

The Royal Gazette published “Canada and cannabis at Year 5,” which focused on three major aspects: the cannabis market, public health and social justice. “Canadian experience demonstrates there have been problems that must be responded to. But the ending of criminalisation that especially burdened Indigenous and Black people, the creation of a legal market providing untainted cannabis — the strength of which is clear — and the confronting of the illicit one that makes vast sums of money, pays no taxes and has no regard for the quality of what it sells must weigh heavily in the balance.”

https://www.royalgazette.com/opinion-writer/opinion/article/20231028/canada-and-cannabis-at-year-5/


What We Heard Report

The federal government released a report that summarizes what a “five-person expert panel has heard over the past year as it engaged with almost 500 stakeholders in nearly 90 meetings across Canada.”

The report, titled “What We Heard,” describes the scope of the engagement and summarizes the responses in several categories including: public health, impact on young persons, impact on First Nations and more.

Read about the expert panel and review here: https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/cannabis-act-legislative-review/expert-panel/legislative-review-cannabis-act-report.html

Read the report here: https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/cannabis-act-legislative-review/expert-panel/legislative-review-cannabis-act-report.html

Stratcann summarized the report in an article published on their website on October 10, 2023, the same day the report was released.

Read the Stratcann article here: https://stratcann.com/other/canada-releases-what-we-heard-report-on-the-cannabis-act-review/

Global News followed up the release of the report with an in-depth article on the state of the cannabis industry in Canada. In the feature published on October 16, 2023, Global News offers commentary by several experts including George Smitherman, president and chief executive of the Cannabis Council of Canada.

Read the Global News article here: https://globalnews.ca/news/10027112/cannabis-act-review-canada/


Exporting Cannabis to the EU

In a previous post, we discussed how some Canadian producers are selling excess inventory to export markets, including Europe.

In “The Europe Medical Cannabis Market,” Market Data Forecast reports, “The medical cannabis market in Europe is expected to grow from USD 4.96 billion in 2022 to USD 13.37 billion by 2027, growing at a CAGR [compound annual growth rate] of CAGR 21.96% from 2022 to 2027.”

Based on that report, Europe appears to be a significant marketplace for cannabis. But to sell into that market, the exporter must meet the region’s standards. In the case of Europe, those standards include the European Union’s Good Manufacturing Practices, referred to as EU GMP.

In their article, “A Look at Canadian Cannabis Exports,” published in 2021, The Business of Cannabis reported one reason why exports jumped in 2020. “In Canada, more cultivators gained the European Union’s Good Manufacturing Practices (EU GMP) certification, allowing them to export to that continent. More than a dozen Canadian LPs now have EU GMP certified facilities.”

Meeting EU GMP standards is critical for exporting into the European marketplace. But what is EU GMP and how does it differ from the standards Canadian companies already meet?

Health Canada requires that Canadian licensed producers comply with Good Production Practices or GPP standards. If you are a licensed producer in Canada, you are already familiar with GPP. If not, these standards are explained on the Health Canada website.

Essentially, GPP requires that cannabis businesses have appropriate procedures for all activities related to producing a product that is safe for public consumption. GPP mandates that systems be in place to ensure quality and traceability.

Good Manufacturing Practices, GMP, takes GPP further including requiring more stringent testing.

The Foundation of Cannabis Unified Standards (FOCUS) states, “GMP is the proactive part of quality assurance. It is designed to minimize the risks involved in all steps of the manufacturing process. A basic tenant of GMP is that quality cannot be tested into a product. It must be built into each batch of product during all stages of the manufacturing process.”

Originally designed for pharmaceutical products, GMP can be applied to any production process and is a requirement for those wishing to market medical cannabis in Europe.

The EU GMP standards are complex, and the information can be difficult to navigate, especially how it applies to cannabis.

But the Canadian government has published guidelines designed to help manufacturers meet GMP standards. Their guidance document has been written “with a view to harmonize with GMP standards from: the World Health Organization (WHO); the Pharmaceutical Inspection Cooperation/Scheme (PIC/S); the International Council on Harmonisation (ICH); the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); other regulatory agencies in other countries.”

While the EU is not mentioned specifically, these Canadian standards are a good starting point for cannabis companies considering exporting into other markets. These guidelines will help producers understand what is required and can be used as a stepping stone toward EU GMP certification.

According to the media, the EU standards are stringent, and certification can be time consuming and costly. But with a market as large as Europe, Canadian companies are in a position to benefit from the opportunities that an EU GMP certificate can offer.


Can Canadian Producers Export Excess Supply?

With media reporting oversupply challenges in the Canadian cannabis industry, can producers turn to export markets to sell their inventory? The answer might be yes. As countries around the world legalize cannabis, new opportunities are emerging for producers in Canada.

Canadian companies have been exporting cannabis for several years already. In fact, back in June 2020, MJBizDaily published a two-part article on Canada’s export of medical cannabis during 2019. Part 1 was titled, “Canada exported record amount of dried cannabis in 2019…” Part 2 reported, “Canadian exports of medical cannabis oil jumped fivefold in 2019.”

Canadian Regulatory Review reported in September of 2020 that the Canadian government had even become supportive of cannabis exports. “On the export side, and to further bolster trade, as of January 2020, the federal government through Canada’s Trade Commissioner Service extended trade commissioner services for Canadian cannabis companies exporting cannabis for medical and scientific purposes.”

A few months after that article, in April 2021, Prohibition Partners released a report called “Revealed: The Canadian Cannabis Export Market for 2020.” The report notes that the largest export markets for Canada at the time were Germany, Australia, Israel and the United Kingdom. “…new data shows a huge increase in the exports of cannabis from the country in 2020, as well as a changing network of countries that are importing from established producers in Canada.”

In May of that same year, Business of Cannabis took “A look at Canadian cannabis exports,” noting that “Dried cannabis flower and cannabis oil exports more than doubled in 2020, while imports dropped to virtually zero…”

An article titled, “How Canada’s Oversupply of Cannabis Is an Export Opportunity,” was published in October of 2022 by Canadian Cannabis Exchange. “As the demand for cannabis legalization increases internationally, Canada has the opportunity to become the world leader in cannabis exports… The European Union is proving to be a lucrative market for Canadian exports.”


Thanks for visiting us at Lift Expo Toronto 2023!

The Toronto Lift Conference and Expo for 2023 happened last week at the The Metro Toronto Convention Centre.

What a great event with leading-edge content, live music, celebrity cameos, prize giveaways and more.

We’d like to thank everyone who dropped by our booth in the expo hall. We greeted as many of our customers (current and future!) as we could, and our team gave everyone a preview of the exciting changes happening to AirMed.

Thanks again for making Lift 2023 Toronto such an  amazing experience for us.

For more information visit: Lift Expo

If you want a reminder of what AirMed has to offer for 2023, visit https://airmedcloud.com/intro-airmed-5/

For a personal tour of our software by one of our team members, click Request Demo at the top of the page or use the contact form in the footer.


See you this Friday at Lift Expo Toronto 2023!

The Toronto Lift Conference and Expo for 2023 is happening this week at the The Metro Toronto Convention Centre.

This event promises leading-edge content, live music, celebrity cameos, prize giveaways and more.

We’re setting up to greet as many of our customers (current and future!) as we can in booth 1023 in the expo hall. Our team can’t wait to show you the exciting changes to AirMed in person on Friday June 2.

For more information visit: Lift Expo

Certified Budtenders get free admission to the expo! Click here for more information: https://liftexpo.ca/tickets-toronto-2023/

If you want an advance peak at what AirMed has to offer for 2023, visit https://airmedcloud.com/intro-airmed-5/

For a personal tour by one of our team members, click Request Demo at the top of the page or use the contact form in the footer.


Lift Expo Toronto 2023 fast approaching Jun 1-3

The next Lift Expo is only weeks away taking place this June 1-3, 2023. Thousands of cannabis industry members are expected at this event being held at the The Metro Toronto Convention Centre.

Lift begins with the business conference on June 1, followed by an industry day on June 2.

Visit AirMed and hundreds of other exhibitors at the expo. Our team can’t wait to show you the exciting changes to AirMed in person in booth 1023 on June 2.

For more information visit: Lift Expo

If you are a Certified Budtender, your admission to the expo is free! Click here for more information: https://liftexpo.ca/tickets-toronto-2023/

For an advance peak at what AirMed has to offer for 2023, visit https://airmedcloud.com/intro-airmed-5/

For a personal tour by one of our team members, click Request Demo at the top of the page or use the contact form in the footer.


Health Canada Seeks Your Feedback from March 25 to May 24, 2023

In relation to a consultation on potential amendments to the Cannabis Regulations, Health Canada is seeking feedback and comments on potential amendments to the Cannabis Regulations.

The aims of the consultation include clarifying existing requirements, eliminating regulation inefficiencies and duplications and reducing administrative and regulatory burdens, and Health Canada is seeking input from:

  • cannabis industry stakeholders
  • public health stakeholders, non-governmental organizations
  • researchers and research or academic institutions
  • First Nations, Inuit and Métis partners and organizations
  • law enforcement
  • provincial, territorial and municipal governments

For more information including how you can provide feedback until May 24, 2023, visit:
https://www.canada.ca/en/health-canada/programs/consultation-potential-amendments-cannabis-regulations.html


Visit us at Lift Expo Toronto 2023: Jun 1-3

The Lift & Co. Expo will be making its return to Toronto this June 1-3, 2023, and AirMed will be there!

Join Lift at The Metro Toronto Convention Centre for the next strategy-focused, advocacy-oriented business and community leadership conference. A can’t-miss for industry members across the cannabis ecosystem, this is your front row seat for the conversations that will drive meaningful change and sustainable growth in the year to come.

Visit us in booth 1023 at the the expo, which spans two high-energy days connecting the cannabis community with hundreds of companies from every corner of our industry. We can’t wait to show you all the exciting changes happening to AirMed in person.

For more information visit: Lift Expo


Canadian Cannabis: State of the Industry Report

The industry analysts at Ernst & Young have published a state of the industry report for the Canadian cannabis industry. Covering until the end of 2022, this report was “intended to highlight the key issues facing the cannabis industry and provide the supporting evidence.”

The executive summary highlights:
1. Successes of legalization;
2. Key issues facing the industry;
3. Key implications and takeaways, and
4. Future policy considerations

The methodology used to create the report including secondary and primary research to identify high-level successes and issues since inception of the Cannabis Act.


Thanks for Visiting us at Lift Expo in Vancouver!

Thanks to everyone who dropped by our booth at the Lift Expo last week at the Vancouver Convention Centre.

We had a great time giving software demos and answering your questions about the new enterprise cannabis management features being added to AirMed in 2023.

We can’t wait to hear from you in the future and hope to see you again soon.

For more information about AirMed 5 visit: https://airmedcloud.com/intro-airmed-5/

For more information visit: Lift Expo


AirMed will be at Lift Expo this week in Vancouver

It’s just a couple of days until Lift Vancouver January 12-14, 2023 at the Vancouver Convention Centre.

Find us in booth 1312 in the expo hall where we will be ready to answer all your questions about the new enterprise cannabis management features being added to AirMed in 2023.

We can’t wait to see you at this event jam-packed with business-building content, captivating speakers, brand discovery, networking and so much more.

We will be showcasing AirMed 5 in booth 1312 in the expo hall.

For more information about AirMed 5 visit: https://airmedcloud.com/intro-airmed-5/

For more information visit: Lift Expo


Visit AirMed at Lift Expo Vancouver 2023

Three days jam-packed with business-building content, captivating speakers, brand discovery, networking and so much more await attendees at Lift Vancouver January 12-14, 2023 at the Vancouver Convention Centre.

With a renewed vision, signature Ah-Ha! moments, and a focus on the unique needs of audiences across the full cannabis ecosystem, Lift Vancouver 2023 is not to be missed.

The three-day event kicks off on Thursday, January 12, with the Lift Cannabis Business Conference, a strategy-focused, advocacy-oriented business conference intent on meaningful change and sustainable growth in the industry. On Friday, January 13 and Saturday, January 14, the Lift expo floor will showcase a wide array of leading and emerging exhibitors while debuting fresh experiences, education and activations.

We will be showcasing AirMed 5 in booth 1312 in the expo hall. For more information about this new enterprise cannabis management system visit: https://airmedcloud.com/intro-airmed-5/

For more information visit: Lift Expo


Less than a month to Lift Expo Vancouver 2023

Following a three-year hiatus, Lift returns to the Vancouver Convention Centre on January 12-14, 2023, and AirMed will  be there! Don’t miss this premiere event, showcasing leading-edge content, hundreds of exhibiting companies and the best networking in the business!

Lift Cannabis Business Conference

A strategy-focused, advocacy-oriented business and community leadership conference intent on meaningful change and sustainable growth in the cannabis industry. Topics will include: The ‘Team Canada’ Approach, Raising Capital, Advocacy & Lobbying, Cannabis Blockchain, Indigenous Cannabis, Speed Breeding and more.

Lift Expo Days

The expo spans two high-energy days connecting the cannabis community with hundreds of exhibiting companies. Plus, two all-new neighborhoods, the Brand Discovery Zone and Micro & Small Batch Craft Growers Area, will bring fresh experiences to budtenders and consumers while showcasing and serving brands and growers.

Education & Experience!

Also brand-new for 2023, our Expo Floor stages will feature new content presented interactively for small groups, including Q&A’s and fireside chats. Don’t miss our famous Lift After Party, plus our signature surprises and a-ha moments.

AirMed is proud to be an exhibitor at the Vancouver Lift show in 2023. Visit us in booth 1312 in the expo hall.

For more information visit: Lift Expo


Lift Expo Vancouver 2023: Jan 12-14

The Lift & Co. Expo will be making its return to Vancouver January 12-14 at Vancouver Convention Centre.

Lift is a strategy-focused, advocacy-oriented business and community leadership conference intent on meaningful change and sustainable growth in the cannabis industry. Topics will include: The ‘Team Canada’ Approach, Raising Capital, Advocacy & Lobbying, Cannabis Blockchain, Indigenous Cannabis, Speed Breeding and More!

Visit AirMed in booth 1312 in the expo hall at LIFT 2023.

For more information visit: Lift Expo